Gilead Sciences Announces Third Quarter 2017 Financial Results

Go back to Gilead Sciences Announces Third Quarter 2017 Financial Results

Gilead Sciences (GILD) Tops Q3 EPS by 14c

October 26, 2017 4:04 PM EDT

Gilead Sciences (NASDAQ: GILD) reported Q3 EPS of $2.27, $0.14 better than the analyst estimate of $2.13. Revenue for the quarter came in at $6.51 billion versus the consensus estimate of $6.39 billion.

For earnings history and earnings-related data on Gilead Sciences (GILD) click here.

... More